Alnylam Pharmaceuticals
Michael Luciano is a Senior Scientist at Alnylam Pharmaceuticals, responsible for leading oncology research. Before joining Alnylam, Michael worked as a Postdoctoral Fellow at the National Cancer Institute, where Michael developed a novel fluorophore-linker combination for cancer imaging applications. At the University of Connecticut, Michael conducted research on photoacoustic imaging contrast agents and metal-ion chemosensors while also serving as a Teaching Assistant and General Chemistry Demonstrator. As a Process Chemistry Intern at ArQule, Michael synthesized a competitor drug for comparison studies. Michael holds a Ph.D. in Chemistry from the University of Connecticut and a BS in Chemistry from Merrimack College.
This person is not in the org chart
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.